Exelixis, Inc.

NasdaqGS:EXEL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 10.31 B

Share Price

USD 38.31

Avg Daily Volume

3,475,404

Change (1 day)

-0.42%

Change (1 year)

45.61%

Change (YTD)

15.04%

Exelixis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending July 04, 2025: 35.80%

Exelixis, Inc. EBITDA Margin is 35.80% for the Trailing 12 Months (TTM) ending July 04, 2025, a 67.92% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Exelixis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 28, 2024 was 21.32%, a 120.55% change year over year.
Exelixis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 9.67%, a -57.20% change year over year.
Exelixis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending July 01, 2022 was 22.59%, a 133.70% change year over year.
Exelixis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending July 02, 2021 was 9.66%, a -71.08% change year over year.